RxDoctor Payments Data

Neil Gross, MD

Otolaryngology · Houston, TXNPI 1841208378

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.8%), education and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 23.6%. Reporting peaked in 2024 at $18,292 and has fallen 99.4% since, to $116 in 2025. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$82,762in general payments, 2019–2025

Across 87 payments — averaging $951.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$20K
  • Regeneron$18K
  • Sanofi-aventis U.S. LLC$13K
  • Sanofi$12K
  • Regeneron Healthcare Solutions, Inc.$10K
  • Merck$10K
  • plus $286 from 2 others
$1,425,071in research payments, 2019–2025

Across 54 payments — averaging $26,390 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$1.2M
  • Ascendis Pharma Endocrinology Inc$208K

What the payments were for

  • Consulting fees$46,98657%
  • Speaking & faculty fees$14,43517%
  • Travel & lodging$4,9596%
  • Food & beverage$1,6782%
  • Education$14,70518%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$82,762 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.

See all otolaryngology providers in Texas

Medicare billing

Part B allowed, 2024
$80,286
Medicare patients
219
Services billed
442

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other otolaryngology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →